SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-016597
Filing Date
2023-12-18
Accepted
2023-12-18 16:30:23
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 form4-12182023_041213.html 4  
1 form4-12182023_041213.xml 4 3148
  Complete submission text file 0001415889-23-016597.txt   4522
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
CAUSEY CHRISTOPHER (Reporting) CIK: 0001237334 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 231494164